{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:26:52Z","timestamp":1782476812704,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00467-025-06785-3","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:59:14Z","timestamp":1747209554000},"page":"621-631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["When our treatment is complicated: an overview of drug-induced acid\u2013base disorders: part 1\u2014acidosis"],"prefix":"10.1007","volume":"41","author":[{"given":"Giulia","family":"Florio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Bockenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"6785_CR1","first-page":"41","volume":"30","author":"TJ Morgan","year":"2009","unstructured":"Morgan TJ (2009) The Stewart approach \u2013 one clinician\u2019s perspective. Clin Biochem Rev 30:41\u201354","journal-title":"Clin Biochem Rev"},{"key":"6785_CR2","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJMra1003327","volume":"371","author":"K Berend","year":"2014","unstructured":"Berend K, De Vries APJ, Gans ROB (2014) Physiological approach to assessment of acid\u2013base disturbances. N Engl J Med 371:1434\u20131445. https:\/\/doi.org\/10.1056\/NEJMra1003327","journal-title":"N Engl J Med"},{"key":"6785_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/resp.12225","volume":"19","author":"AL Byrne","year":"2014","unstructured":"Byrne AL, Bennett M, Chatterji R, Symons R, Pace NL, Thomas PS (2014) Peripheral venous and arterial blood gas analysis in adults: are they comparable? A systematic review and meta-analysis. Respirology 19:168\u2013175. https:\/\/doi.org\/10.1111\/resp.12225","journal-title":"Respirology"},{"key":"6785_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2165\/00139709-200322030-00001","volume":"22","author":"AT Proudfoot","year":"2003","unstructured":"Proudfoot AT, Krenzelok EP, Brent J, Vale JA (2003) Does urine alkalinization increase salicylate elimination? If so, why? Toxicol Rev 22:129\u2013136. https:\/\/doi.org\/10.2165\/00139709-200322030-00001","journal-title":"Toxicol Rev"},{"key":"6785_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2125.2010.03765.x","volume":"71","author":"AD Shah","year":"2011","unstructured":"Shah AD, Wood DM, Dargan PI (2011) Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. Br J Clin Pharmacol 71:20\u201328. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03765.x","journal-title":"Br J Clin Pharmacol"},{"key":"6785_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2215\/CJN.01411005","volume":"1","author":"AZ Fenves","year":"2006","unstructured":"Fenves AZ, Kirkpatrick HMI, Patel VV, Sweetman L, Emmett M (2006) Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol 1:441. https:\/\/doi.org\/10.2215\/CJN.01411005","journal-title":"Clin J Am Soc Nephrol"},{"key":"6785_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5863\/1551-6776-19.4.277","volume":"19","author":"TY Lim","year":"2014","unstructured":"Lim TY, Poole RL, Pageler NM (2014) Propylene glycol toxicity in children. J Pediatr Pharmacol Ther 19:277\u2013282. https:\/\/doi.org\/10.5863\/1551-6776-19.4.277","journal-title":"J Pediatr Pharmacol Ther"},{"key":"6785_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/s0272-6386(97)90577-1","volume":"30","author":"PD Yorgin","year":"1997","unstructured":"Yorgin PD, Theodorou AA, Al-Uzri A, Davenport K, Boyer-Hassen LV, Johnson MI (1997) Propylene glycol-induced proximal renal tubular cell injury. Am J Kidney Dis 30:134\u2013139. https:\/\/doi.org\/10.1016\/s0272-6386(97)90577-1","journal-title":"Am J Kidney Dis"},{"key":"6785_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","volume":"65","author":"R DeFronzo","year":"2016","unstructured":"DeFronzo R, Fleming GA, Chen K, Bicsak TA (2016) Metformin-associated lactic acidosis: current perspectives on causes and risk. Metab Clin Exp 65:20\u201329. https:\/\/doi.org\/10.1016\/j.metabol.2015.10.014","journal-title":"Metab Clin Exp"},{"key":"6785_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1001\/archinte.162.4.434","volume":"162","author":"AT Calabrese","year":"2002","unstructured":"Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH (2002) Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 162:434\u2013437. https:\/\/doi.org\/10.1001\/archinte.162.4.434","journal-title":"Arch Intern Med"},{"key":"6785_CR11","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","volume":"24","author":"RW Hunter","year":"2018","unstructured":"Hunter RW, Hughey CC, Lantier L, Sundelin EI, Peggie M, Zeqiraj E, Sicheri F, Jessen N, Wasserman DH, Sakamoto K (2018) Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nat Med 24:1395\u20131406. https:\/\/doi.org\/10.1038\/s41591-018-0159-7","journal-title":"Nat Med"},{"key":"6785_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/0885066618793385","volume":"34","author":"GS Wang","year":"2019","unstructured":"Wang GS, Hoyte C (2019) Review of biguanide (metformin) toxicity. J Intensive Care Med 34:863\u2013876. https:\/\/doi.org\/10.1177\/0885066618793385","journal-title":"J Intensive Care Med"},{"key":"6785_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3109\/15563650.2014.987397","volume":"52","author":"JB Mowry","year":"2014","unstructured":"Mowry JB, Spyker DA, Cantilena LR, McMillan N, Ford M (2014) 2013 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol 52:1032\u20131283. https:\/\/doi.org\/10.3109\/15563650.2014.987397","journal-title":"Clin Toxicol"},{"key":"6785_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00431-005-1634-y","volume":"164","author":"M Lacher","year":"2005","unstructured":"Lacher M, Hermanns-Clausen M, Haeffner K, Brandis M, Pohl M (2005) Severe metformin intoxication with lactic acidosis in an adolescent. Eur J Pediatr 164:362\u2013365. https:\/\/doi.org\/10.1007\/s00431-005-1634-y","journal-title":"Eur J Pediatr"},{"key":"6785_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1345\/aph.10116","volume":"34","author":"HA Spiller","year":"2000","unstructured":"Spiller HA, Weber JA, Winter ML, Klein-Schwartz W, Hofman M, Gorman SE, Stork CM, Krenzelok EP (2000) Multicenter case series of pediatric metformin ingestion. Ann Pharmacother 34:1385\u20131388. https:\/\/doi.org\/10.1345\/aph.10116","journal-title":"Ann Pharmacother"},{"key":"6785_CR16","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.5001\/omj.2020.104","volume":"35","author":"R Al-Abdwani","year":"2020","unstructured":"Al-Abdwani R (2020) Metformin-induced lactic acidosis reported in the youngest pediatric patient with impaired renal function. Oman Med J 35:e162. https:\/\/doi.org\/10.5001\/omj.2020.104","journal-title":"Oman Med J"},{"key":"6785_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s13181-013-0325-8","volume":"10","author":"AM Margolis","year":"2014","unstructured":"Margolis AM, Heverling H, Pham PA, Stolbach A (2014) A review of the toxicity of HIV medications. J Med Toxicol 10:26\u201339. https:\/\/doi.org\/10.1007\/s13181-013-0325-8","journal-title":"J Med Toxicol"},{"key":"6785_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1086\/339041","volume":"34","author":"V Falc\u00f3","year":"2002","unstructured":"Falc\u00f3 V, Rodr\u00edguez D, Ribera E, Mart\u00ednez E, Mir\u00f3 JM, Domingo P, Diazaraque R, Jos\u00e9 RA, Gonz\u00e1lez-Garc\u00eda JJ, Montero F, S\u00e1nchez L, Pahissa A (2002) Severe nucleoside-associated lactic acidosis in human immunodeficiency virus\u2013infected patients: report of 12 cases and review of the literature. Clin Infect Dis 34:838\u2013846. https:\/\/doi.org\/10.1086\/339041","journal-title":"Clin Infect Dis"},{"key":"6785_CR19","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","volume":"354","author":"S Blanche","year":"1999","unstructured":"Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, Ciraru-Vigneron N, Lacroix C, Rouzioux C, Mandelbrot L, Desguerre I, R\u00f6tig A, Mayaux M-J, Delfraissy J-F (1999) Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354:1084\u20131089. https:\/\/doi.org\/10.1016\/S0140-6736(99)07219-0","journal-title":"Lancet"},{"key":"6785_CR20","doi-asserted-by":"publisher","unstructured":"Ekouevi DK, Tour\u00e9 R, Becquet R, Viho I, Sakarovitch C, Rouet F, Towne-Gold B, Fassinou P, Leroy V, Blanche S, Dabis F; Agence Nationale de Recherches Sur le SIDA 1201\/1202 Ditrame Plus Study Group (2006) Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les H\u00e9patites Virales 1209 study, Abidjan, Ivory Coast. Pediatrics 118:e1071-1077. https:\/\/doi.org\/10.1542\/peds.2006-0371","DOI":"10.1542\/peds.2006-0371"},{"key":"6785_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","volume":"22","author":"TN Kakuda","year":"2000","unstructured":"Kakuda TN (2000) Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22:685\u2013708. https:\/\/doi.org\/10.1016\/S0149-2918(00)90004-3","journal-title":"Clin Ther"},{"key":"6785_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1081\/NCN-100002341","volume":"20","author":"T Cihlar","year":"2001","unstructured":"Cihlar T, Ho ES, Lin DC, Mulato AS (2001) Human renal organic anion transporter 1 (hoat1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 20:641\u2013648. https:\/\/doi.org\/10.1081\/NCN-100002341","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"6785_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14740338.2017.1335305","volume":"16","author":"A Santini","year":"2017","unstructured":"Santini A, Ronchi D, Garbellini M, Piga D, Protti A (2017) Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes. Expert Opin Drug Saf 16:833\u2013843. https:\/\/doi.org\/10.1080\/14740338.2017.1335305","journal-title":"Expert Opin Drug Saf"},{"key":"6785_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijantimicag.2014.06.017","volume":"44","author":"A Ozkaya-Parlakay","year":"2014","unstructured":"Ozkaya-Parlakay A, Kara A, Celik M, Ozsurekci Y, Karadag Oncel E, Ceyhan M, Cengiz AB (2014) Early lactic acidosis associated with linezolid therapy in paediatric patients. Int J Antimicrob Agents 44:334\u2013336. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.06.017","journal-title":"Int J Antimicrob Agents"},{"key":"6785_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5863\/1551-6776-11.1.17","volume":"11","author":"EM Timpe","year":"2006","unstructured":"Timpe EM, Eichner SF, Phelps SJ (2006) Propofol-related infusion syndrome in critically ill pediatric patients: coincidence, association, or causation? J Pediatr Pharmacol Ther 11:17\u201342. https:\/\/doi.org\/10.5863\/1551-6776-11.1.17","journal-title":"J Pediatr Pharmacol Ther"},{"key":"6785_CR26","doi-asserted-by":"publisher","first-page":"e30383","DOI":"10.7759\/cureus.30383","volume":"14","author":"A Singh","year":"2022","unstructured":"Singh A, Anjankar AP (2022) Propofol-related infusion syndrome: a clinical review. Cureus 14:e30383. https:\/\/doi.org\/10.7759\/cureus.30383","journal-title":"Cureus"},{"key":"6785_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bja.2018.12.025","volume":"122","author":"S Hemphill","year":"2019","unstructured":"Hemphill S, McMenamin L, Bellamy MC, Hopkins PM (2019) Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth 122:448\u2013459. https:\/\/doi.org\/10.1016\/j.bja.2018.12.025","journal-title":"Br J Anaesth"},{"key":"6785_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman JC, Verdin E (2017) \u03b2-hydroxybutyrate: a signaling metabolite. Annu Rev Nutr 37:51\u201376. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064916","journal-title":"Annu Rev Nutr"},{"key":"6785_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41581-024-00836-y","volume":"20","author":"DV O\u2019Hara","year":"2024","unstructured":"O\u2019Hara DV, Lam CSP, McMurray JJV, Yi TW, Hocking S, Dawson J, Raichand S, Januszewski AS, Jardine MJ (2024) Applications of SGLT2 inhibitors beyond glycaemic control. Nat Rev Nephrol 20:513\u2013529. https:\/\/doi.org\/10.1038\/s41581-024-00836-y","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"6785_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/dmrr.2924","volume":"33","author":"JE Blau","year":"2017","unstructured":"Blau JE, Tella SH, Taylor SI, Rother KI (2017) Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data. Diabetes Metab Res Rev 33:1002. https:\/\/doi.org\/10.1002\/dmrr.2924","journal-title":"Diabetes Metab Res Rev"},{"key":"6785_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antibiotics12010142","volume":"12","author":"A Nocentini","year":"2023","unstructured":"Nocentini A, Capasso C, Supuran CT (2023) Carbonic anhydrase inhibitors as novel antibacterials in the era of antibiotic resistance: where are we now? Antibiotics 12:142. https:\/\/doi.org\/10.3390\/antibiotics12010142","journal-title":"Antibiotics"},{"key":"6785_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00467-023-06084-9","volume":"39","author":"Y Bulkowstein","year":"2024","unstructured":"Bulkowstein Y, Nitzan-Luques A, Schnapp A, Barnoy N, Reif S, Gilboa T, Volovesky O (2024) The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension. Pediatr Nephrol 39:185\u2013191. https:\/\/doi.org\/10.1007\/s00467-023-06084-9","journal-title":"Pediatr Nephrol"},{"key":"6785_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1365-2125.2009.03521.x","volume":"68","author":"N Mirza","year":"2009","unstructured":"Mirza N, Marson AG, Pirmohamed M (2009) Effect of topiramate on acid\u2013base balance: extent, mechanism and effects. Br J Clin Pharmacol 68:655\u2013661. https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03521.x","journal-title":"Br J Clin Pharmacol"},{"key":"6785_CR34","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1093\/ndt\/gfl251","volume":"21","author":"A Sacr\u00e9","year":"2006","unstructured":"Sacr\u00e9 A, Jouret F, Manicourt D, Devuyst O (2006) Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrol Dial Transplant 21:2995\u20132996. https:\/\/doi.org\/10.1093\/ndt\/gfl251","journal-title":"Nephrol Dial Transplant"},{"key":"6785_CR35","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1177\/0300060516669897","volume":"44","author":"H T\u00fcre","year":"2016","unstructured":"T\u00fcre H, Keskin \u00d6, \u00c7ak\u0131r \u00dc, Aykut Bing\u00f6l C, T\u00fcre U (2016) The frequency and severity of metabolic acidosis related to topiramate. J Int Med Res 44:1376\u20131380. https:\/\/doi.org\/10.1177\/0300060516669897","journal-title":"J Int Med Res"},{"key":"6785_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1528-1157.2001.04500.x","volume":"42","author":"M Takeoka","year":"2001","unstructured":"Takeoka M, Holmes GL, Thiele E, Bourgeois BF, Helmers SL, Duffy FH, Riviello JJ (2001) Topiramate and metabolic acidosis in pediatric epilepsy. Epilepsia 42:387\u2013392. https:\/\/doi.org\/10.1046\/j.1528-1157.2001.04500.x","journal-title":"Epilepsia"},{"key":"6785_CR37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00467-008-1036-2","volume":"24","author":"D Bockenhauer","year":"2009","unstructured":"Bockenhauer D, Hug MJ, Kleta R (2009) Cystic fibrosis, aminoglycoside treatment and acute renal failure: the not so gentle micin. Pediatr Nephrol 24:925\u2013928. https:\/\/doi.org\/10.1007\/s00467-008-1036-2","journal-title":"Pediatr Nephrol"},{"key":"6785_CR38","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.ekir.2023.08.031","volume":"8","author":"RE Campbell","year":"2023","unstructured":"Campbell RE, Chen CH, Edelstein CL (2023) Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep 8:2211\u20132225. https:\/\/doi.org\/10.1016\/j.ekir.2023.08.031","journal-title":"Kidney Int Rep"},{"key":"6785_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneph.2009.17","volume":"5","author":"R Zietse","year":"2009","unstructured":"Zietse R, Zoutendijk R, Hoorn EJ (2009) Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol 5:193\u2013202. https:\/\/doi.org\/10.1038\/nrneph.2009.17","journal-title":"Nat Rev Nephrol"},{"key":"6785_CR40","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/qjmed\/hct258","volume":"107","author":"AM Hall","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ (2014) Drug-induced renal Fanconi syndrome. QJM 107:261\u2013269. https:\/\/doi.org\/10.1093\/qjmed\/hct258","journal-title":"QJM"},{"key":"6785_CR41","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller RP, Tadagavadi RK, Ramesh G, Reeves WB (2010) Mechanisms Cisplatin Nephrotoxicity. Toxins 2:2490\u20132518. https:\/\/doi.org\/10.3390\/toxins2112490","journal-title":"Mechanisms Cisplatin Nephrotoxicity Toxins"},{"key":"6785_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/ckj\/sfaa017","volume":"13","author":"B Sprangers","year":"2020","unstructured":"Sprangers B, Lapman S (2020) The growing pains of ifosfamide. Clin Kidney J 13:500\u2013503. https:\/\/doi.org\/10.1093\/ckj\/sfaa017","journal-title":"Clin Kidney J"},{"key":"6785_CR43","doi-asserted-by":"publisher","unstructured":"Knights M, Thekkekkara T, Morris A, Finlay E (2016) Sodium valproate-induced Fanconi type proximal renal tubular acidosis. BMJ Case Rep 2016:bcr2015213418. https:\/\/doi.org\/10.1136\/bcr-2015-213418","DOI":"10.1136\/bcr-2015-213418"},{"key":"6785_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pediatrneurol.2022.03.001","volume":"130","author":"DA Sturla \u00c1lvarez","year":"2022","unstructured":"Sturla \u00c1lvarez DA, S\u00e1nchez Marcos E, de Lucas CC, Cantar\u00edn Extremera V, Soto Insuga V, Aparicio L\u00f3pez C (2022) Fanconi syndrome secondary to sodium valproate therapy: experience and literature review. Pediatr Neurol 130:53\u201359. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2022.03.001","journal-title":"Pediatr Neurol"},{"key":"6785_CR45","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41598-020-58386-9","volume":"10","author":"EM Gottwald","year":"2020","unstructured":"Gottwald EM, Schuh CD, Dr\u00fccker P, Haenni D, Pearson A, Ghazi S, Bugarski M, Polesel M, Duss M, Landau EM, Kaech A, Ziegler U, Lundby AKM, Lundby C, Dittrich PS, Hall AM (2020) The iron chelator Deferasirox causes severe mitochondrial swelling without depolarization due to a specific effect on inner membrane permeability. Sci Rep 10:1577. https:\/\/doi.org\/10.1038\/s41598-020-58386-9","journal-title":"Sci Rep"},{"key":"6785_CR46","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/vox.13064","volume":"116","author":"JC Yui","year":"2021","unstructured":"Yui JC, Geara A, Sayani F (2021) Deferasirox-associated Fanconi syndrome in adult patients with transfusional iron overload. Vox Sang 116:793\u2013797. https:\/\/doi.org\/10.1111\/vox.13064","journal-title":"Vox Sang"},{"key":"6785_CR47","doi-asserted-by":"publisher","first-page":"G573","DOI":"10.1152\/ajpgi.00338.2001","volume":"282","author":"Z Wang","year":"2002","unstructured":"Wang Z, Petrovic S, Mann E, Soleimani M (2002) Identification of an apical Cl(-)\/HCO3(-) exchanger in the small intestine. Am J Physiol Gastrointest Liver Physiol 282:G573\u2013G579. https:\/\/doi.org\/10.1152\/ajpgi.00338.2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6785_CR48","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1592\/phco.29.5.554","volume":"29","author":"AB Pai","year":"2009","unstructured":"Pai AB, Shepler BM (2009) Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications. Pharmacotherapy 29:554\u2013561. https:\/\/doi.org\/10.1592\/phco.29.5.554","journal-title":"Pharmacotherapy"},{"key":"6785_CR49","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.xkme.2020.05.015","volume":"2","author":"SM Herrmann","year":"2020","unstructured":"Herrmann SM, Alexander MP, Romero MF, Zand L (2020) Renal tubular acidosis and immune checkpoint inhibitor therapy: an immune-related adverse event of PD-1 inhibitor\u2014a report of 3 cases. Kidney Med 2:657\u2013662. https:\/\/doi.org\/10.1016\/j.xkme.2020.05.015","journal-title":"Kidney Med"},{"key":"6785_CR50","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s0002-9343(99)80017-5","volume":"98","author":"JR Oster","year":"1995","unstructured":"Oster JR, Singer I, Fishman LM (1995) Heparin-induced aldosterone suppression and hyperkalemia. Am J Med 98:575\u2013586. https:\/\/doi.org\/10.1016\/s0002-9343(99)80017-5","journal-title":"Am J Med"},{"key":"6785_CR51","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/nm.2497","volume":"17","author":"EJ Hoorn","year":"2011","unstructured":"Hoorn EJ, Walsh SB, McCormick JA, F\u00fcrstenberg A, Yang C-L, Roeschel T, Paliege A, Howie AJ, Conley J, Bachmann S, Unwin RJ, Ellison DH (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med 17:1304\u20131309. https:\/\/doi.org\/10.1038\/nm.2497","journal-title":"Nat Med"},{"key":"6785_CR52","volume-title":"Essentials of medical biochemistry : with clinical cases","author":"NV Bhagavan","year":"2015","unstructured":"Bhagavan NV, Ha C-E (2015) Essentials of medical biochemistry\u202f: with clinical cases. Academic Press, Amsterdam"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06785-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:02:06Z","timestamp":1769608926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06785-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["6785"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06785-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}